Tampa General Hospital continues to be the best hospital in the Tampa Bay area, as today’s release of the 2023-24 rankings by U.S. News & World Report show.

Today’s U.S. News announcement also recognized 11 Tampa General specialties for their strong national reputation and performance, including six in the nation’s top 50 and three in the top 20. Many of the 11 specialties are led or co-led by USF Health faculty physicians.

“Tampa General’s strong showing in this year’s rankings is a testament to the compassionate care and clinical expertise of our primary teaching partner,” said Dr. Charles J. Lockwood, executive vice president of USF Health and dean of USF Health Morsani College of Medicine.

“I’m so proud of our physicians and the leadership they have provided in propelling so many specialties to be among the best in the nation. These rankings translate into saving patients’ lives across Tampa Bay and beyond.”

Dr. Lockwood is also the executive vice president and chief academic officer of Tampa General Hospital.

The six specialties ranked among the top 50 in the nation are:

• Obstetrics and Gynecology – ranked #9 in the U.S. and #1 in Florida
• Gastroenterology and GI Surgery – ranked #19 in the U.S. and #1 in Florida
• Diabetes & Endocrinology – ranked #18 in the U.S. and #2 in Florida
• Ear, Nose & Throat – ranked #39 in the U.S. and #2 in Florida
• Orthopedics – ranked #30 in the U.S. and #2 in Florida
• Urology – ranked #49 in the U.S. and #2 in Florida

In addition, five more specialties were recognized as “high performing” and among the top 10% in the nation:

• Cancer
• Cardiology & Heart Surgery
• Geriatrics
• Neurology & Neurosurgery
• Pulmonology & Lung Surgery

The USF Health Morsani College of Medicine Class of 2023 held their graduation ceremony at the Straz Center for the Performing Arts May 11.

Cheers and tears of joy filled the Straz Center for the Performing Arts in Tampa as students of the USF Health Morsani College of Medicine Class of 2023, along with their families and friends, brought a four-year medical school journey to an end during a commencement ceremony May 11.

The 179 senior medical students of the Class of 2023 represented a transitional period for the Morsani College of Medicine. The group was the last to begin medical school at the USF Health main campus location in north Tampa. They finished medical school in the new Morsani College of Medicine and Heart Institute in downtown Tampa. Additionally, they were one of few graduating classes to experience medical school before, during and after the COVID-19 pandemic.

Rhea Law, JD, president of the University of South Florida. 

Kicking off the ceremony was Rhea Law, JD, president of the University of South Florida and an alumna of USF. In her address to the students, she urged the students to be in a state of constant reflection and display perseverance as they work toward their goals in health care.

“Before you walk across the stage, I encourage you to reflect on your ‘why?’ Why did you choose the University of South Florida for your medical education? Why did you choose to become a health care professional?” said Law.  “I urge you to keep pursuing your goals and never underestimate yourselves. You can accomplish anything you set your mind to.”

Charles J. Lockwood, MD, MHCM, executive vice president of USF Health and dean of the USF Health Morsani College of Medicine. 

Charles J. Lockwood, MD, MHCM, executive vice president of USF Health and dean of the USF Health Morsani College of Medicine, next addressed the students. He complimented the class on their perseverance and their unique perspective on how crucial patient-centered health care is during and after a pandemic.

“You had front-row seats to observe that those who practice medicine are vital to preserving our society.  Your own education was disrupted, access to research impaired, and despite the demands of learning your craft, you volunteered countless hours at COVID test sites and clinics,” Dr. Lockwood said. “You’ve arrived here today because your sustained commitment to the noble goal of becoming a physician and your resilience has paid off. I speak for all of USF Health when I say we could not be prouder of you.”

Stephen Liggett, MD, vice dean of research for the Morsani College of Medicine and associate vice president for research at USF Health, was designated a Distinguished Professor by Charles Lockwood, MD, MHCM, executive vice president for USF Health and dean of the Morsani College of Medicine. 

Read Dr. Lockwood’s complete remarks here. 

Following his remarks, Dr. Lockwood named Stephen Liggett, MD, a USF Health Distinguished Professor.  He is the vice dean of research for the Morsani College of Medicine and  associate vice president for research at USF Health.  The designation is given to senior staff and faculty who have distinguished themselves within and outside of USF Health.  Dr. Lockwood said Dr. Liggett exemplifies all three of USF Health’s missions: research, clinical care, and education.

Jane Castor, mayor of the City of Tampa, received the 2023 Dean’s Award from Charles Lockwood, MD, MHCM, executive vice president of USF Health and dean of the Morsani College of Medicine. 

Dr. Lockwood also presented Jane Castor, mayor of the City of Tampa, with the 2023 Dean’s Award for her swift actions taken to help mitigate the spread of COVID-19 in Tampa.  Additionally, Dr. Lockwood commended her for her “sure and steady hand” as he described her leadership through other public health crises including access to vaccinations, and actions taken before, during and after Hurricane Ian.

“Never become complacent. Always stay curious. Treat every one of your patients as if they were a family member. Wherever your life’s journey takes you, remember you always have a home here in the city of Tampa,” Castor said in her address to the students. “No one arrives in the position you’re in without the assistance of others and that rings true for the Dean’s Award as well. I accept that with a great deal of gratitude. But also with the understanding of all of the hands that went into our community and region being able to navigate the pandemic as successfully as we did.”

Following Mayor Castor’s remarks, Bryan Bognar, MD, MPH, FACP, vice dean for educational affairs at the Morsani College of Medicine and chair of the Department of Medical Education, welcomed the newest member of the MCOM Academy of Distinguished Educators, Vinita Kiluk, MD. Dr. Kiluk has distinguished herself as both a clinician and educator.  She is a pediatrician and co-course director for Doctoring 3.

Bri Anne McKeon, MD, FACOG, assistant dean for clinical curriculum at the Morsani College of Medicine, led the students in the Oath of Hippocrates. USF President Rhea Law conferred the Doctor of Medicine degree to the class, signifying their official transition from medical student to doctor.

One by one, students came center stage to be presented their academic hoods by Milind Kothari, DO, FAAN, and Marna Greenberg, DO, MPH.

After all students received their hoods, a special group of students took center stage for a different type of ceremony; a military commissioned officer promotion ceremony. Air Force Capts. Ana Capati-Fernandez, MD, Tyler Palbicke, MD, Emma Weiland, MD, and Army Capt. Erik Este, MD, were welcomed by a thunderous ovation from the crowd in recognition of their commitment as doctors and as military officers. After reciting the Oath of Office, family members came on stage to pin their new rank on their shoulders.

Left to right: Air Force Capt. Ana Capati-Fernandez, MD, Army Capt. Erik Este, MD, Air Force Capts. Tyler Palbicke, MD, and Emma Weiland, MD, recite the Oath of Commissioning prior to being promoted.

Paige DeBlieux, MD, co-president of the Class of 2023, was voted on by her classmates to deliver the farewell speech. Her message was one of hope and comradery. “Cling to your principles and ideals. Seek contentedness where you are. When others are choosing the route of selfishness, I hope that you cling to what is right. Meet failure and disappointment with courage. Failure and disappointment are necessary to experience success and fulfillment.”

Deborah DeWaay, MD, FACP, associate dean of undergraduate medical education for the Morsani College of Medicine, delivered the charge speech to the students. “It doesn’t matter what culture you’re from, what religion or lack thereof you practice, what part of the world you live, wherever you live, life and balance have never gone together. Life is messy, and fantastic,” she said to the class.

The new doctors will take the next step in their careers when they begin their residencies July 1.

More photos from the ceremony:

Story and photos by Freddie Coleman, video by Allison Long, USF Health Office of Communications.

This year’s USF Health Research Day set new records as more participants than ever filled the USF Tampa campus Marshall Student Center on March 3 to showcase the best of their scientific work.

The 33^rd USF Health Research Day included 457 research poster presentations by students, postdocs, residents, faculty, and staff across all health disciplines. Research Day is the largest research-oriented event of its kind at USF and remains the largest celebration of health sciences research collaboration across all four USF Health colleges (medicine, nursing, public health and pharmacy) as well as with colleagues in other USF colleges, including social work and engineering.

From left, Dr. Charles Lockwood, Dr. Kim Orth, Rhea Law, and Dr. Steve Liggett.

Research Day kicked off with the Annual Roy H. Behnke, MD, Distinguished Lectureship featuring speaker Kim Orth, PhD, professor of Molecular Biology and Biochemistry at University of Texas Southwestern Medical Center and an investigator at the Howard Hughes Medical Institute, at UT Southwestern Medical Center.

Dr. Orth’s presentation was titled “Black Spot, Black Death, Black Pearl: Tales of Bacterial Effectors” – click here for more about Dr. Orth and her work.

Dr. Kim Orth.

* * *

Tampa General Hospital, the primary teaching hospital for USF Health Morsani College of Medicine, was the presenting sponsor for USF Health Research Day 2023.

Following Dr. Orth’s presentation was the judging of work. Judges reviewed the posters that lined the Marshall Center Ballroom, asking the students for more detail and clarifications about their research projects. Presentations ranged from pilot, preliminary, empirical and case studies to system reviews and reviews of literature or charts.

Following the 13^th Annual Joseph Krzanowski Invited Oral Presenters by select students representing medicine, nursing, public health, and pharmacy, Research Day culminated with an Awards Ceremony in the Oval Theatre announcing the winners in 29 competitive categories – including 18 monetary awards totaling $8,600.

* * *

For the list of Research Day 2023 award winners, click here.

For the list of Research Day judges and sponsors, click here.

More photos

Photos by Freddie Coleman, video by Allison Long, USF Health Communications

Leaders from USF Health and the Global Virus Network (GVN) recently gathered on the University of South Florida campus in north Tampa to sign the final documents making it official that USF Health serves as GVN’s Southeast United States Regional Headquarters.

USF Health and GVN announced nearly two years ago that USF Health earned the designation, but COVID-19 delayed the official signing until this year. The signing took place at the USF Lifsey House Feb 27, 2023, and marks the advancement of the collaborative relationship among the two organizations.

From left, Dr. Charles Lockwood, Pres. Rhea Law, Mathew Evins, and Dr. Christian Brechot.

“What we are signing together today marks a first, that USF is the first regional headquarters to be created with GVN,” said Christian Bréchot, MD, PhD, president of GVN; associate vice president for International Partnerships and Innovation at USF; director of the USF Microbiomes Institute, and professor in the Division of Infectious Disease, Department of Internal Medicine at the USF Health Morsani College of Medicine. “This headquarters at USF will allow GVN to expand its outreach into Florida with USF’s academic, research and medical activities and expertise, including USF’s international activities. In turn, GVN will provide to USF increased visibility and critical mass across the globe in the field of virology.”

“We are so excited to be the headquarters for the Global Virus Network,” said USF President Rhea Law. “This is an initiative in which we can have enhanced collaborations that focus on huge issues affecting our world today. We can make a difference. Thank you so much for all you’ve done. We are looking forward to our collaboration and to our next steps in opportunities to change the world.”

“We are very grateful to be the Southeast Regional Headquarters and this is a significant stepping stone to where we are headed in virology,” said Charles J. Lockwood, MD, executive vice president of USF Health and dean of the USF Health Morsani College of Medicine. “One of the key elements of putting this all together is Christian Bréchot. He has been such an incredible resource, for recruitment of virologists, addressing microbiome, and strengthening many of our programs. It has been a joy to see this collaboration develop and grow. So now, the sky is the limit with this great team in place.”

“On behalf of Bob Gallo, the Board of Directors, and the leadership of the Global Virus Network, I would like to express our most profound appreciation to the University of South Florida for its invaluable and instrumental partnership,” Mathew Evins, executive chair and treasurer of the GVN Board of Directors and chair of Evins Communications, Ltd. “I’ve been involved with GVN from the beginning and I cannot think of a situation where I have been more proud. This is a very significant step for us because the key to the successes of GVN in the future are the kind of partnerships we have with the University of South Florida. This for us is not an incremental step; it is an exponential step. I could not be more grateful for your support, your encouragement, and your partnership.”

GVN encompasses the world’s foremost virologists from 71 centers of excellence and 9 affiliates in 40 nations – all working to prevent illness and death from viral diseases posing threats to humanity. Bridging academia, government and industry, the coalition is internationally recognized as an authority and resource for identifying, investigating, interpreting, explaining, controlling, and suppressing viral diseases.

USF Health was the first regional headquarters named by GVN to provide organizational and leadership support to GVN’s Global Headquarters in Baltimore, Md. In that capacity, USF Health will help strengthen GVN’s initial research response to emerging and re-emerging infectious diseases, such as COVID-19, and its collaborative efforts to plan for, and defend against, future epidemics and pandemics.

Since announcing USF Health’s designation as the GVN Southeast United States Regional Headquarters, the two organization have launched several programs, including the Global Health Conversation Series with USF Health International that hosted a recent webinar featuring Rachel Roper, MS, PhD, who spoke on Monkeypox virus, vaccines and virulence; Dr. Bréchot’s Health and Care Blog that provides updates on novel insights into the COVID-19 pandemic; One Health Codeathon, an effort between GVN and the USF Genomics Program that provides students the opportunity to learn how to harness data sciences against pandemics; and submission of several joint grant applications, including to the National Science Foundation and the National Institutes of Health.

The GVN Southeast U.S. Regional Headquarters based at USF Health will encompass the four health sciences colleges of the university: the USF Health Morsani College of Medicine, the College of Nursing, the College of Public Health, and the USF Health Taneja College of Pharmacy. USF Health is an integral part of USF, a high-impact global research university dedicated to student success. Over the past 10 years, no other public university in the country has risen faster in U.S. News and World Report’s national university rankings than USF.

The appearance of COVID-19 has transformed society almost beyond recognition, with lasting implications for health care, the economy and our social and psychological well-being. Together we can, and we must, be better prepared to meet the challenges of the next emerging virus.”

In addition to their leadership roles at GVN Global Headquarters in Baltimore, Md., Dr. Bréchot and GVN Vice President Linman Li of the USF Health Division of Infectious Disease and International Medicine will lead the new GVN Southeast U.S. Regional Headquarters and focus on regional efforts to expand government and other research funding, as well as research and training initiatives. The regional headquarters designation will enable USF Health scientists to partner with GVN experts worldwide to share ideas and research, to translate research into practical applications, to improve diagnostics and therapies, and to develop vaccines.

GVN members collaborate on science-driven, independent research in many areas, including immunology and vaccines, antiviral drug therapy, virus-host interaction, diagnostic virology and epidemiology, morphogenesis and structural biology, emerging and re-emerging viruses, viruses as biotechnological tools, and trending topics in virology. They also train the next generation of virologists to combat the epidemics of the future.

Video by Allison Long, photos by Freddie Coleman, USF Health Communications

Authors often compare publishing a book to birthing a baby – a metaphor that is even more apt when the book in question is THE medical textbook on high-risk pregnancy, delivery, and fetal health.

At 1,494 pages, the 9^th edition of Creasy & Resnick’s Maternal-Fetal Medicine: Principles and Practice weighs in at 9.79 pounds – a good two pounds heftier than the average newborn baby. Clad in a glossy purple cover, it is a book that demands attention on any shelf.

“I should have warned you guys to bring a wheelbarrow for your books,” joked Dr. Judette Louis, professor and chair of Obstetrics and Gynecology (OB/GYN) at the USF Health Morsani College of Medicine and one of seven co-editors of the newest edition.

The department celebrated the publication of the new edition with a book-signing breakfast Wednesday for its trainees: 24 OB/GYN residents and four fellows in Maternal-Fetal Medicine (MFM). Both Dr. Louis and Dr. Charles J. Lockwood, dean of the Morsani College of Medicine and executive vice president of USF Health, were on hand to sign each copy. The publisher describes the book as “the definitive reference in the field for more than 35 years.”

“I am incredibly honored that Drs. Creasy and Resnik honored me as the new chief editor,” said Dr. Lockwood. He noted that the book would be 400 or so pages longer if it included all the references, which are only listed online.

“It’s definitely a great weight-bearing exercise,” joked Dr. Lockwood about the textbook’s heft.

Jokes aside, the residents said the book signing was a nice recognition that the physicians they are learning from are among the nation’s top experts.

“Knowing that we have some of the best mentors in the field as we go on to our careers – I think it’s inspiring,” said resident Dr. Rachelle Price, who will start her MFM fellowship next year.

“It’s amazing,” said Dr. Danielle Hardman. “I went to medical school here, so Dr. Lockwood’s been here during all my time here. It’s an honor” to have her textbook signed by him.

Resident Dr. Brittany Manobianco said one of her friends, who is going into MFM, was especially excited to get her copy.

“This is her Taylor Swift tour,” she proclaimed.

Perhaps fortunately, Ticketmaster did not work on the books – but the editors definitely did. Each editor was assigned a different section of the book, which includes chapters by a variety of authors who are experts on a variety of maternal and fetal high-risk conditions, such as premature labor and pregnancy-related hypertension. Editors conducted multiple levels of review and fact checks to ensure that each chapter reflects the latest science, evidence and best practices.

And then they proofed it all over again.

“I read every word in this book,” Dr. Lockwood said. “Every. Single. Word.”

Just how familiar is Dr. Lockwood with Creasy & Resnick?

Back when he was an MFM fellow himself, Dr. Lockwood studied the textbook’s first edition.

Photos by Allison Long, USF Health Communications.

The USF Health Morsani College of Medicine is the fastest-rising medical school in the country, climbing over the last decade from #80 to #46 in U.S. News & World Report rankings for medical schools for research.

Based on data from U.S. News & World Report Academic Insights, the Morsani College of Medicine has climbed 34 spots in rankings for 2014 to 2023. No other medical school in the data – public or private – has risen as far in rankings as fast as the Morsani College of Medicine.

In the last decade, the USF Health Morsani College of Medicine has made great strides, pushing metrics upward in the college’s three mission areas — education, research and patient care – in an effort to place the college among the best medical schools in the country.

With improved metrics, the college’s placement in the national rankings soared from No. 80 in the 2014 U.S. News list to No. 46 in the recently published 2023 list – a seismic 34 spots.

No other medical school in the country has experienced that same improvement in rankings, making the USF Health Morsani College of Medicine the fastest-rising medical schools in the country.

“Our sustained rise in national rankings reflects the rapidly increasing strength of our educational, research and clinical missions at the USF Health Morsani College of Medicine. We are now competing with the nation’s most storied and respected programs,” said Dr. Charles Lockwood, senior vice president for USF Health and dean of the USF Health Morsani College of Medicine. “These outstanding metrics also position us to attract the highest caliber students and faculty, further advancing our program into the national spotlight for its outstanding education, exceptional research and world class clinical care.”

Tampa General Hospital is once again the #1 hospital in the Tampa Bay area and is now tied for third among Florida hospitals, as listed by U.S. News & World Report 2022-23 rankings released today.

In the listing, U.S. News recognized 12 USF Health and Tampa General specialties for their strong national reputation and performance, including seven in the top 50 – USF Health doctors lead or co-lead most of these top-ranked specialties.

The news shines a light on the many USF Health faculty who care for patients within these specialties, seeing patients at Tampa General and within USF Health clinical facilities, said Dr. Charles J. Lockwood, senior vice president at USF Health and dean of the USF Health Morsani College of Medicine.

“This national recognition is a wonderful achievement, built upon the dedication, compassion and commitment to world-class care that our physicians and providers deliver every day,” Dr. Lockwood said. “I would like to thank each of them, as well as all of our Tampa General caregivers and colleagues, for their continuing pursuit of excellence and belief in making life better for residents of Tampa Bay and beyond.”

The seven specialties ranked among the top 50 in the nation are:

• Diabetes & Endocrinology – #27
• Ear, Nose & Throat – #16
• Gastroenterology and GI Surgery – #34
• Obstetrics & Gynecology – #40
• Orthopedics – #33
• Pulmonology – #49
• Rehabilitation – #40

Five more specialties were recognized as “high performing,” and are among the top 10% in the nation:

• Cancer
• Cardiology & Heart Surgery
• Geriatrics
• Neurology & Neurosurgery
• Urology

The USF Health Center for Advanced Medical Learning and Simulation (CAMLS) first opened 10 years ago in March 2012, where leaders from the community, education, industry, and simulation partners from around the world met for the grand opening in downtown Tampa.

Under one roof, the 90,000 square-foot, three-story facility houses the latest simulation technology and experiences to train the full spectrum of health care professionals as one of the nation’s top medical simulation facilities.

Part of the mosaic of USF Health’s expanded presence in downtown Tampa, CAMLS, is within walking distance of the USF Health Morsani College of Medicine and Heart Institute in the Water Street Tampa urban development district.

CAMLS Grand Opening

“The goal was to build almost a Disney World for clinical providers who could travel from around the world to CAMLS to train with the best technology using simulation, incredible bio skills, fully realistic labs so that they can improve their procedural and clinical skills and then go back to their work and give the best practices both from USF Health experts but also utilizing the latest and greatest technology,” said Dr. Yasuharu “Haru” Okuda, MD, FACEP, FSSH, executive director for USF Health CAMLS and associate vice president for USF Health Interprofessional Education and Practice.

Until recently, CAMLS focused solely on training biomedical businesses and health care professionals. However, that initiative has expanded over the years to offer hands-on simulation training to USF Health students and faculty dedicated to advancing their clinical skills and improving patient safety and quality of care in Tampa Bay, Florida, the U.S., and the world.

“In the beginning, this advanced medical learning simulation was really focused around businesses and training and teaching health care professionals. But over the years, we’ve really evolved into a place where we conduct research in even more advanced training and education, like in virtual reality and augmented reality. We also now impact our future health care professionals by training students from our College of Medicine and College of Nursing both separately and as part of interprofessional teams,” Dr. Okuda said.

Dr. Charles Lockwood and USF President Rhea Law.

USF President Rhea H. Law and Charles Lockwood, MD, MHCM, senior vice president for USF Health and dean of the Morsani College of Medicine (MCOM), have been active participants and contributed greatly to the success of CAMLS. President Law has been on the board of directors over the years and has continued to support the organization. Meanwhile, Dr. Lockwood has helped support the efforts of CAMLS around education, research, and innovation.

EMS instructors participated in a training class hosted by the USF Health CAMLS at the Pinellas County EMS Training Center.

Recently, CAMLS has been working on a new community outreach program called “CAMLS Without Walls.” The program was developed so the facility could go out into the community and deliver training through simulation-based education.

“The future of CAMLS is really bright,” Dr. Okuda said. “We have some incredible partnerships with startup companies in Tampa, where we’re building on our business relationships to innovate in areas such as virtual reality and augmented reality. We are also building our research teams to identify new technologies for training and education, and we’re publishing articles on that research. Now we are building a mobile training program called “CAMLS Without Walls,” so we are not bound by training only within CAMLS but can now go out into our community and deliver the training in hospitals in our rural environments and bring USF Health Expertise to places that need it the most.”

Story and video by Ryan Rossy, USF Health Communications and Marketing

Collaborative effort across Florida’s medical schools results in a statute expanding Medicaid coverage to include donor breastmilk

More Florida babies will have access to donor breastmilk with the recent passing of a bill in the Florida Legislature allowing Medicaid to help cover the cost. The bill, signed by Gov. Ron DeSantis last month, will become law July 1, 2022, and will greatly expand access to donor breastmilk for babies in neonatal intensive care units (NICUs) across the state. Hitherto, Florida Medicaid typically only covered infant formula for hospitalized babies who did not have access to their mothers’ milk.

The report that helped create the bill was provided by the Florida Medical Schools Quality Network (FMSQN), a cooperative of research, clinical, and educational experts from Florida’s medical schools that aims to improve quality of care in Florida’s Medicaid Program. FMSQN worked with USF Health College of Public Health alumnae Jan Gorrie, of Ballard Partners, to help navigate the bill through Florida Legislature’s bill processes. The FMSQN report was commissioned by the Agency for Health Care Administration.

“This collaboration among academic clinicians, State government policy makers, child advocates, government affairs professionals, and legislators converted data to action in supporting evidence-based access to donor breastmilk for Florida’s infants, and serves as an example of opportunities to improve health outcomes for infants, children, and adolescents in Medicaid programs.  We would like to thank Senator Lauren Book and Representative Fiona McFarland for sponsoring this legislation, and for Governor DeSantis’ timely approval during this time of a national critical formula shortage” said Charles J. Lockwood, MD, MHCM, senior vice president of USF Health, dean of the USF Health Morsani College of Medicine, and president of the FMSQN.

FMSQN member organizations include: Florida International University Herbert Wertheim College of Medicine; Florida State University College of Medicine; Lake Erie College of Osteopathic Medicine; Nova Southeastern University Dr. Kiran C. Patel College of Allopathic Medicine; Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine; University of Central Florida College of Medicine; University of Florida College of Medicine; University of Miami Leonard M. Miller School of Medicine; and the USF Health Morsani College of Medicine.

FMSQN was instrumental in conducting a survey of Florida’s NICUs current usage of donor human milk. The results and subsequent meetings with state legislators informed the crafting of Florida Senate Bill (SB) 1770 / House Bill (HB) 1577, which mandated Florida Medicaid coverage of pasteurized donor human milk (PDHM) and derivatives by accredited donor human milk banks and regulatory agency approved private milk banks.

Data showed that, if these NICUs did not provide PDHM, there would be an estimated increase of 138 more infants per year developing necrotizing enterocolitis (NEC), a potential fatal, severe gastrointestinal disease frequently requiring surgery and long-term nutritional support at an annualized cost of $5,175,000. Thus, PDHM use in Florida would avoid an estimated $4 million in health care expenditures annually, and may save more when the hospital readmissions, home health care visits, and emergency department visits are considered that were not factored into the calculations.

“The initiative was a success because of a team effort with academic health centers, State leaders, child and mother advocates, and community stakeholders,” Dr. Lockwood said. “And it’s these fragile babies in our hospitals who will benefit the most from this successful piece of legislation.”

Nanotechnology and biotechnology experts from around the globe gathered in-person and virtually at this year’s Global Nanobiotechnology Conference (GNC), hosted April 22 to 24 by USF’s NANO and Engineering Biology student organizations and the USF Health Taneja College of Pharmacy.

Nearly 170 attendees representing researchers from across the United States, as well as a global reach to India, Turkey, Azerbaijan and Colombia, registered for this conference’s second annual event, all benefiting from the opportunity to network and foster scientific and research collaborations. Poster presentations and oral presentations at the event highlighted current work being done in the fields of nano-technology and biotechnology.

USF President Rhea Law urged attendees to continue their life-saving work.

“I’m proud that the University of South Florida is hosting such a critically important event –given the global devastation and calamity that COVID-19 has caused in the last two years,” said USF President Rhea Law in her remarks to conference attendees. “But this has made the work you do all the more vital. There is a dire need to continue innovating nano-biotech-based approaches to manage the pandemic. A global crisis like this one requires intensive collaboration and interdisciplinary research, uniting the most creative minds in tackling it. And that is precisely what this conference helps to accomplish–bringing together scientists from medicine to physics, material science, molecular biology, and biomedical engineering to find new solutions to COVID and other threats to humankind.”

Charles Lockwood, MD, MHCM, senior vice president for USF Health and dean of the Morsani College of Medicine, also share a message of support.

“The University of South Florida takes great pride in its status as a global research university and this conference offers a great opportunity to continue building a worldwide network of faculty, scientists and industry partners dedicated to innovating nano-biotech research,” Dr. Lockwood said. “This weekend you will hear from some of the world’s top experts discussing advancements in nanotechnology, and the implication for improving health care across the globe.”

This year’s conference was chaired by Shyam Mohapatra, PhD, MBA, professor and associate dean of the USF Health Taneja College of Pharmacy. The annual event is motivated by the need for developing nanobiotechnologies for current COVID-19 pandemic and such pandemics in the future.

The interdisciplinary nature of nanobiotechnology brings together scientists from medicine, physics, material science, molecular biology, and biomedical engineering, among other disciplines, to find solutions for challenging problems that humankind is facing with transdisciplinary approaches. The role of nanotechnology has been clearly illustrated in the novel methods of diagnosis, vaccines, and treatments, which have been developed against COVID-19.